Table 3. Factors significantly associated with mean birth weight (Multivariate analysis performed on 1439 women and adjusted on bed net, education).

		Adjusted difference in mean birth weight (g)	95% Confidence interval	p
First dose intake	6–7 months of gestation	0
	5 months of gestation	72.5	[18.7, 126.4]	0.008
	4 months of gestation	138.2	[75.25 200.9]	<0.001
Interval time between the 2 doses	≤31 days	0
	32–37 days	12.0	[−47.0, 71.1]	0.69
	38–61 days	3.2	[−59.8, 66.3]	0.98
	>62 days	−33.1	[−107.9, 41.7]	0.36
Parity	Multigravidae	0
	Primigravidae	−179.7	[−230.6, −128.8]	<0.001
Study	STOPPAM	0
	Ouidah trial	63.1	[1.6, 124.6]	0.04
Underweight	BMI*≥20	0
	BMI<20	−132.5	[−178.0, −87.0]	<0.001
Duration of pregnancy	≥40 weeks of gestation	0
	39 weeks of gestation	−147.9	[−196.8, −99.0]	<0.001
	≤38 weeks of gestation	−422.4	[−477.3, −367.5]	<0.001
Newborn's gender	Male	0
	Female	−100.4	[−142.1, −58.7]	<0.001
Number of consultations	≥5 consultations	0
	<5 consultations	−66.1	[−110.0, −22.1]	0.03
Transmission period	Dose 1 and dose 2 during rainy season	0
	Dose 1 during rainy season and dose 2 during dry season	26.5	[−43.9, 96.9]	0.46
	Dose 1 during dry season and dose 2 during rainy season	44.3	[−25.9, 114.5]	0.22
	Dose 1 and dose 2 during dry season	73.1	[10.6, 135.6]	0.02

^*Body mass index.